Research and Markets: 2013 Report on the International Liver Diseases Therapeutics Market - Global Forecasts to 2018

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/9z9dc5/liver_diseases) has announced the addition of the "2013 Report on the International Liver Diseases Therapeutics Market - Global Forecasts to 2018" report to their offering.

"2013 Report on the International Liver Diseases Therapeutics Market - Global Forecasts to 2018", explores the global market for liver diseases therapeutics is classified into seven drug class segments namely, anti-viral drugs, vaccines, immunosuppressants, immunoglobulins, targeted therapy, corticosteroids and chemotherapy with their estimated and forecasted market size from 2012 to 2018, along with their compound annual growth rate.

The market players considered are: Abbott Laboratories, Astellas Pharma Inc, Gilead Science Inc., Merck & Co., Bristol-Myers Squibb, Novartis, Pfizer and Roche. A detailed analysis of their business strategies, company overview, financial overview, product portfolio and recent developments is also provided in the report.

Secondary research was utilized for deriving our market numbers for each segment of the research report and further validated our analysis with C-level executives of major companies operating in liver diseases therapeutics market through the means of primary research to finally come up with our results. This research is specially designed to estimate and analyze the performance of liver diseases therapeutics in a global scenario. This research provides in-depth analysis of liver diseases therapeutics market sales, trend analysis by segments.

Key Topics Covered:

1 Preface

2 Executive Summary

3 Market Overview

3.1 Introduction

3.2 Market Size

3.3 Comparative Analysis Of Global Liver Diseases Therapeutics Market, By Drug Class, 2011 & 2018

3.4 Liver Diseases Therapeutics Market Dynamics

3.5 Porter's Five Forces Analysis For Liver Diseases Therapeutics Market

4 Liver Diseases Classification And Therapy Options

4.1 Alcohol Induced Liver Disease

4.2 Autoimmune Liver Disorder

4.3 Hepatocellular Carcinoma

4.4 Non-Alcoholic Fatty Liver Disease

4.5 Viral/Hepatitis Liver Disorder

5 Liver Diseases Therapeutics Market, By Drug Class

5.1 Immunosuppressants

5.2 Chemotherapy Drugs

5.3 Targeted Therapy Drugs

5.4 Vaccines

5.5 Anti-Viral Drugs

5.6 Immunoglobulins

5.7 Corticosteriods

6 Competitive Landscape

7 Recommendations

8 Company Profiles

Companies Mentioned:

  • Abbott Laboratories
  • Astellas Pharma
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche Ltdmerck & Co
  • Gilead Sciences
  • Glaxosmithkline
  • Novartis
  • Pfizer
  • Sanofi
  • Takeda Pharmaceutical
  • Valeant Pharmaceuticals
  • Watson Pharmaceuticals

For more information visit http://www.researchandmarkets.com/research/9z9dc5/liver_diseases

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals